Biden Administration Publishes Unified Agenda, Revealing FDA’s Planned Regulatory Actions for 2023

Christopher Hanson article

The Unified Agenda is a helpful tool in identifying upcoming opportunities for industry to submit public comments on Advance Notices of Proposed Rulemaking (ANPRs) as well as proposed rules and to plan any additional advocacy activities. The Unified Agenda also alerts the public to when FDA intends to finalize a particular rulemaking, enabling industry to anticipate potential new regulatory requirements.


Join now to enjoy expanded member benefits!

Enjoy exclusive member content, special events, savings, networking and more